MedTrace Logo

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension

NCT04994548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2021-08-06

No results posted yet for this study

Summary

Cirrhotic patients may be at high risk for esophageal cancer. Endoscopic resection is the standard treatment for superficial tumors. However, cirrhosis might be associated with upper gastrointestinal bleeding, particularly in case of portal hypertension or coagulopathy. This study aims to assess safety, efficacy and methods to prevent potential complications in cirrhosis or portal hypertension context for esophageal endoscopic resection.

This retrospective multicentric French-Belgian study includes all consecutive patients with cirrhosis or portal hypertension who underwent esophageal endoscopic resection from January 2005 to 2021.

Conditions

  • Esophageal Neoplasms
  • Cirrhosis
  • Portal Hypertension

Interventions

PROCEDURE

Endosocpic resection of early esophageal tumor

under general anesthesia, by mucosectomy or endoscopic submucosal dissection

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-01
Primary Completion
2005-02-03
Completion
2021-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994548 on ClinicalTrials.gov